157 related articles for article (PubMed ID: 1909947)
1. Orthoclone OKT3 and cardiac transplantation: an overview.
Mahon PM
Crit Care Nurse; 1991 Sep; 11(8):42-7, 50. PubMed ID: 1909947
[No Abstract] [Full Text] [Related]
2. Reversing cardiac transplant rejection with Orthoclone OKT3.
Dault LA; Nagy CS; Collins JA
Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
[No Abstract] [Full Text] [Related]
3. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection.
Gilbert EM; Eiswirth CC; Renlund DG; Menlove RL; DeWitt CW; Freedman LA; Herrick CM; Gay WA; Bristow MR
Transplant Proc; 1987 Apr; 19(2 Suppl 1):45-53. PubMed ID: 3105140
[No Abstract] [Full Text] [Related]
4. OKT3 monoclonal antibody in cardiac transplant patients.
Vaska PL
Dimens Crit Care Nurs; 1991; 10(3):126-32. PubMed ID: 1902770
[TBL] [Abstract][Full Text] [Related]
5. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.
Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E
Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455
[No Abstract] [Full Text] [Related]
6. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization.
Moore CK; O'Connell JB; Renlund DG; Bristow MR; Hammond EH
Transplant Proc; 1991 Feb; 23(1 Pt 2):1055-8. PubMed ID: 1899151
[No Abstract] [Full Text] [Related]
7. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Kremer AB; Barnes L; Hirsch RL; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
[No Abstract] [Full Text] [Related]
8. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
[No Abstract] [Full Text] [Related]
9. Orthoclone OKT3: an overview of the monoclonal antibody and the nursing considerations it presents.
Pezze JL; Whiteman K
Crit Care Nurse; 1991 May; 11(5):98-102, 104-7. PubMed ID: 1902767
[No Abstract] [Full Text] [Related]
10. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
[No Abstract] [Full Text] [Related]
11. Therapy of refractory, recurrent heart rejection with multiple courses of OKT3.
Frist WH; Gerhardt EB; Merrill WH; Atkinson JB; Eastburn TE; Stewart JR; Hammon JW; Bender HW
J Heart Transplant; 1990; 9(6):724-6. PubMed ID: 2126035
[TBL] [Abstract][Full Text] [Related]
12. Meningism in a ten-month-old infant during OKT3 therapy.
Rizzo JD; Rowe SA
J Heart Transplant; 1990; 9(6):727-8. PubMed ID: 2126036
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
[TBL] [Abstract][Full Text] [Related]
14. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
15. Orthoclone OKT3 treatment of acute renal allograft rejection.
Friedman J; Barnes L; Sheahan M; Tsai H; Goldstein G
Transplant Proc; 1987 Apr; 19(2 Suppl 2):46. PubMed ID: 3105144
[No Abstract] [Full Text] [Related]
16. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
17. Immunologic monitoring with Orthoclone OKT3 therapy.
Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
[TBL] [Abstract][Full Text] [Related]
18. OKT3 delays rejection crises after heart transplantation.
Weimar W; Essed CE; Balk AH; Simoons ML; Hendriks GF; Wenting GJ; Mochtar B; Bos E
Transplant Proc; 1989 Feb; 21(1 Pt 3):2497-8. PubMed ID: 2495641
[No Abstract] [Full Text] [Related]
19. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.
O'Connell JB; Bristow MR; Hammond EH; Menlove RL; Ensley RD; Ratkovec RM; Renlund DG
Transplant Proc; 1991 Feb; 23(1 Pt 2):1157-9. PubMed ID: 1899154
[No Abstract] [Full Text] [Related]
20. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
